RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation

Area of Science:

• Immunology
• Molecular Biology
• Virology

Background:

• RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine with dual roles in immune responses and HIV infection.
• At high concentrations, RANTES can paradoxically enhance HIV infection, a phenomenon linked to its aggregation.
• Understanding RANTES aggregation is crucial for elucidating its complex biological functions.

Purpose of the Study:

• To investigate the mechanism of RANTES-induced T cell activation.
• To compare the effects of aggregated versus disaggregated RANTES on antigen-specific CD8(+) T cell clones.
• To identify inhibitors of RANTES-mediated activation and their mechanisms.

Main Methods:

• Studied antigen-specific CD8(+) T cell clones.
• Compared effects of aggregated and disaggregated RANTES.
• Utilized specific antigens and RANTES inhibitors (glycosaminoglycans, MIP-1alpha, MIP-1beta).
• Analyzed cell surface marker expression and cytokine secretion (IFN-gamma, MIP-1beta).

Main Results:

• Observed significant RANTES aggregation on the cell surface.
• RANTES aggregation induced T cell activation, including marker up-regulation and cytokine release.
• Inhibitors prevented RANTES binding to the cell surface, blocking activation.
• RANTES demonstrated properties more akin to a mitogen than an antigen-independent activator.

Conclusions:

• RANTES aggregation on cell surfaces is a key mechanism for T cell activation.
• Soluble inhibitors effectively block RANTES-induced activation by preventing cell surface binding.
• The findings suggest RANTES functions primarily as a mitogen in this context, influencing immune cell behavior.